Loading...
•
Jul 31
Cooper Q3 2025 Earnings Report
Cooper reported Q3 2025 results with revenue and EPS growth driven by operational excellence and strong margins.
Key Takeaways
CooperCompanies delivered solid Q3 performance with 6% revenue growth, strong free cash flow, and raised earnings guidance, despite revenue coming in slightly below expectations.
Revenue reached $1.06B, up 6% YoY
GAAP EPS was $0.49, while non-GAAP EPS rose to $1.10
Net income totaled $98.3M for the quarter
Free cash flow was strong at $164.6M, supported by $261.5M in cash from operations
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Toric & Multifocal Revenue
CapyFin.comSphere & Other Revenue
CapyFin.comOffice & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
CooperCompanies raised its non-GAAP EPS guidance for Q4 and reaffirmed confidence in long-term growth, expecting better revenue performance driven by MyDay®.
Positive Outlook
- Raised non-GAAP EPS guidance for Q4 2025 to $1.10 - $1.14
- Full-year 2025 revenue expected to reach $4.076B - $4.096B
- Organic revenue growth projected at 4% to 4.5% for FY25
- Strong momentum anticipated in Q4 and FY26 driven by MyDay®
- Free cash flow generation remains robust
Challenges Ahead
- Q3 revenue came in below expectations
- Gross margin decreased slightly due to product line exit
- Operating margin declined YoY from 19% to 17%
- Asia Pacific region saw a YoY revenue decline organically
- Fertility segment impacted by minor divestitures
Revenue & Expenses
Visualization of income flow from segment revenue to net income